Moreover, despite the well-known association between ZAG gene expression and several metabolic disorders, such as visceral obesity and metabolic syndrome, decreased basal SAT/VAT ZAG gene expression levels were not linked to poorer outcomes in terms of weight loss 1 year after the surgical procedure. Here, AZGP1 is linked to metabolic disease.